| UniProt ID | TOM5_HUMAN | |
|---|---|---|
| UniProt AC | Q8N4H5 | |
| Protein Name | Mitochondrial import receptor subunit TOM5 homolog | |
| Gene Name | TOMM5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 51 | |
| Subcellular Localization |
Mitochondrion outer membrane Single-pass membrane protein . |
|
| Protein Description | ||
| Protein Sequence | MFRIEGLAPKLDPEEMKRKMREDVISSIRNFLIYVALLRVTPFILKKLDSI | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 1 | Acetylation | -------MFRIEGLA -------CCCCCCCC | 4.61 | 25944712 | |
| 10 | Ubiquitination | RIEGLAPKLDPEEMK CCCCCCCCCCHHHHH | 60.97 | 23000965 | |
| 10 | Ubiquitination | RIEGLAPKLDPEEMK CCCCCCCCCCHHHHH | 60.97 | 21890473 | |
| 10 | Acetylation | RIEGLAPKLDPEEMK CCCCCCCCCCHHHHH | 60.97 | 26051181 | |
| 10 | Sumoylation | RIEGLAPKLDPEEMK CCCCCCCCCCHHHHH | 60.97 | 28112733 | |
| 17 | Ubiquitination | KLDPEEMKRKMREDV CCCHHHHHHHHHHHH | 52.74 | 33845483 | |
| 17 | 2-Hydroxyisobutyrylation | KLDPEEMKRKMREDV CCCHHHHHHHHHHHH | 52.74 | - | |
| 17 | Acetylation | KLDPEEMKRKMREDV CCCHHHHHHHHHHHH | 52.74 | 26051181 | |
| 26 | Phosphorylation | KMREDVISSIRNFLI HHHHHHHHHHHHHHH | 21.40 | 20068231 | |
| 27 | Phosphorylation | MREDVISSIRNFLIY HHHHHHHHHHHHHHH | 17.91 | 20068231 | |
| 46 | Acetylation | RVTPFILKKLDSI-- HHHHHHHHHHHCC-- | 46.61 | 19608861 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TOM5_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TOM5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TOM5_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-46, AND MASS SPECTROMETRY. | |